Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Sales (2016 - 2025)

Tg Therapeutics has reported Return on Sales over the past 10 years, most recently at 0.44% for Q4 2025.

  • Quarterly results put Return on Sales at 0.44% for Q4 2025, down 66.0% from a year ago — trailing twelve months through Dec 2025 was 0.55% (up 48.0% YoY), and the annual figure for FY2025 was 0.55%, up 48.0%.
  • Return on Sales for Q4 2025 was 0.44% at Tg Therapeutics, down from 2.42% in the prior quarter.
  • Over the last five years, Return on Sales for TGTX hit a ceiling of 2.42% in Q3 2025 and a floor of 1005.01% in Q4 2022.
  • Median Return on Sales over the past 5 years was 1.7% (2023), compared with a mean of 87.69%.
  • Biggest five-year swings in Return on Sales: soared 227720bps in 2021 and later plummeted -96450bps in 2022.
  • Tg Therapeutics' Return on Sales stood at 40.51% in 2021, then plummeted by -2381bps to 1005.01% in 2022, then surged by 100bps to 0.33% in 2023, then surged by 168bps to 0.22% in 2024, then tumbled by -296bps to 0.44% in 2025.
  • The last three reported values for Return on Sales were 0.44% (Q4 2025), 2.42% (Q3 2025), and 0.2% (Q2 2025) per Business Quant data.